Our technical advisor, Professor Satoshi Obika from Osaka University Graduate School of Pharmaceutical Sciences, and our President & CEO, Mr. Hideaki Sato, were interviewed by Nikkei Biotech ONLINE.

Please click here for details (Japanese only).